Consistent with our finding, Kantari-Mimoun et al. have reported that activated CAR T cells triggered the up-regulation of ICAM-1 on tumor cells in an IFNγ-dependent pathway that enabled T cell entry into tumor islets (52). Here, ICAM1 is linked to neoplasm.